Haematopoietic stem and progenitor cells from human pluripotent stem cells

Nature

Volumn 545, Issue 7655, 2017, Pages 432-438

  Sugimura, Ryohichi ^a,b,c,d   Jha, Deepak Kumar ^a,b,c,d   Han, Areum ^a,b   Soria Valles, Clara ^a,b,c,d   Da Rocha, Edroaldo Lummertz ^a,b,c,d   Lu, Yi Fen ^a,b,c,d   Goettel, Jeremy A ^a,b   Serrao, Erik ^b   Rowe, R Grant ^a   Malleshaiah, Mohan ^b   Wong, Irene ^e   Sousa, Patricia ^a,b,c,d   Zhu, Ted N ^f   Ditadi, Andrea ^g   Keller, Gordon ^g   Engelman, Alan N ^b   Snapper, Scott B ^a,b,h   Doulatov, Sergei ^a,b,c,d,j   Daley, George Q ^a,b,c,d,i  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c HARVARD STEM CELL INSTITUTE   (United States)

^d Manton Center for Orphan Disease Research   (United States)

^e BRANDEIS UNIVERSITY   (United States)

^f HARVARD UNIVERSITY   (United States)

^g UNIVERSITY HEALTH NETWORK   (Canada)

^h BRIGHAM AND WOMEN S HOSPITAL   (United States)

ⁱ HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^j UNIVERSITY OF WASHINGTON   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR ERG; TRANSCRIPTION FACTOR HOXA10; TRANSCRIPTION FACTOR HOXA5; TRANSCRIPTION FACTOR HOXA9; TRANSCRIPTION FACTOR LCOR; TRANSCRIPTION FACTOR RUNX1; TRANSCRIPTION FACTOR SPI1; UNCLASSIFIED DRUG; ERG PROTEIN, HUMAN; HOMEODOMAIN PROTEIN; HOXA10 PROTEIN, HUMAN; HOXA5 PROTEIN, HUMAN; LCOR PROTEIN, HUMAN; ONCOPROTEIN; PROTO-ONCOGENE PROTEIN SPI-1; REPRESSOR PROTEIN; RUNX1 PROTEIN, HUMAN; TRANSACTIVATOR PROTEIN;

BLOOD; BLOOD SYSTEM DISORDER; CELLS AND CELL COMPONENTS; DISEASE INCIDENCE; EMBRYONIC DEVELOPMENT; GENE EXPRESSION; PROTEIN; RODENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; FEMALE; HEMANGIOBLAST; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; T LYMPHOCYTE; UMBILICAL VEIN ENDOTHELIAL CELL; ANIMAL; CELL DIFFERENTIATION; CELL LINEAGE; CYTOLOGY; ENDOTHELIUM; HEMATOPOIETIC STEM CELL TRANSPLANTATION; METABOLISM; NUCLEAR REPROGRAMMING;

MUS;

ANIMALS; CELL DIFFERENTIATION; CELL LINEAGE; CELLULAR REPROGRAMMING; CORE BINDING FACTOR ALPHA 2 SUBUNIT; ENDOTHELIUM; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELLS; HOMEODOMAIN PROTEINS; HUMANS; MICE; PLURIPOTENT STEM CELLS; PROTO-ONCOGENE PROTEINS; REPRESSOR PROTEINS; TRANS-ACTIVATORS; TRANSCRIPTION FACTORS; TRANSCRIPTIONAL REGULATOR ERG;

EID: 85019667943     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/nature22370     Document Type: Article

References (57)

1. Cahan, P. et al. CellNet: network biology applied to stem cell engineering. Cell 158, 903-915 (2014).
2. Riddell, J. et al. Reprogramming committed murine blood cells to induced hematopoietic stem cells with defined factors. Cell 157, 549-564 (2014).
3. Sandler, V. M. et al. Reprogramming human endothelial cells to haematopoietic cells requires vascular induction. Nature 511, 312-318 (2014).
4. Pereira, C. F. et al. Induction of a hemogenic program in mouse fibroblasts. Cell Stem Cell 13, 205-218 (2013).
5. Szabo, E. et al. Direct conversion of human fibroblasts to sub-lethal blood progenitors. Nature 468, 521-526 (2010).
6. Batta, K., Florkowska, M., Kouskoff, V. & Lacaud, G. Direct reprogramming of murine fibroblasts to hematopoietic progenitor cells. Cell Rep. 9, 1871-1884 (2014).
7. Doulatov, S. et al. Induction of multipotential hematopoietic progenitors from human pluripotent stem cells via respecification of lineage-restricted precursors. Cell Stem Cell 13, 459-470 (2013).
8. Dieterlen-Lievre, F. On the origin of haemopoietic stem cells in the avian embryo: An experimental approach. J. Embryol. Exp. Morphol. 33, 607-619 (1975).
9. Ivanovs, A. et al. Highly potent human hematopoietic stem cells first emerge in the intraembryonic aorta-gonad-mesonephros region. J. Exp. Med. 208, 2417-2427 (2011).
10. Bertrand, J. Y. et al. Haematopoietic stem cells derive directly from aortic endothelium during development. Nature 464, 108-111 (2010).
11. Boisset, J. C. et al. In vivo imaging of haematopoietic cells emerging from the mouse aortic endothelium. Nature 464, 116-120 (2010).
12. Dzierzak, E. & Speck, N. A. Of lineage and legacy: The development of mammalian hematopoietic stem cells. Nat. Immunol. 9, 129-136 (2008).
13. Kennedy, M. et al. T lymphocyte potential marks the emergence of definitive hematopoietic progenitors in human pluripotent stem cell differentiation cultures. Cell Rep. 2, 1722-1735 (2012).
14. Ditadi, A. et al. Human definitive haemogenic endothelium and arterial vascular endothelium represent distinct lineages. Nat. Cell Biol. 17, 580-591 (2015).
15. Elcheva, I. et al. Direct induction of haematoendothelial programs in human pluripotent stem cells by transcriptional regulators. Nat. Commun. 5, 4372 (2014).
16. Ivanova, N. B. et al. A stem cell molecular signature. Science 298, 601-604 (2002).
17. Doulatov, S. et al. Revised map of the human progenitor hierarchy shows the origin of macrophages and dendritic cells in early lymphoid development. Nat. Immunol. 11, 585-593 (2010).
18. Novershtern, N. et al. Densely interconnected transcriptional circuits control cell states in human hematopoiesis. Cell 144, 296-309 (2011).
19. Shultz, L. D. et al. Human lymphoid and myeloid cell development in NOD/ LtSz-scid IL2R gamma null mice engrafted with mobilized human hemopoietic stem cells. J. Immunol. 174, 6477-6489 (2005).
20. Ferrell, P. I., Xi, J., Ma, C., Adlakha, M. & Kaufman, D. S. The RUNX1 + 24 enhancer and P1 promoter identify a unique subpopulation of hematopoietic progenitor cells derived from human pluripotent stem cells. Stem Cells 33, 1130-1141 (2015).
21. Ditadi, A. & Sturgeon, C. M. Directed differentiation of definitive hemogenic endothelium and hematopoietic progenitors from human pluripotent stem cells. Methods 101, 65-72 (2016).
22. McIntosh, B. E. et al. Nonirradiated NOD, B6. SCID Il2r/ KitW41/W41 (NBSGW) mice support multilineage engraftment of human hematopoietic cells. Stem Cell Rep. 4, 171-180 (2015).
23. Casero, D. et al. Long non-coding RNA profiling of human lymphoid progenitor cells reveals transcriptional divergence of B cell and T cell lineages. Nat. Immunol. 16, 1282-1291 (2015).
24. Notta, F. et al. Distinct routes of lineage development reshape the human blood hierarchy across ontogeny. Science 351, aab2116 (2016).
25. Glodek, A. M. et al. Focal adhesion kinase is required for CXCL12-induced chemotactic and pro-adhesive responses in hematopoietic precursor cells. Leukemia 21, 1723-1732 (2007).
26. Hartz, B. et al. 4 integrin levels on mobilized peripheral blood stem cells predict rapidity of engraftment in patients receiving autologous stem cell transplantation. Blood 118, 2362-2365 (2011).
27. Smith-Berdan, S. et al. Robo4 cooperates with CXCR4 to specify hematopoietic stem cell localization to bone marrow niches. Cell Stem Cell 8, 72-83 (2011).
28. Dou, D. R. et al. Medial HOXA genes demarcate haematopoietic stem cell fate during human development. Nat. Cell Biol. 18, 595-606 (2016).
29. Klein, A. M. et al. Droplet barcoding for single-cell transcriptomics applied to embryonic stem cells. Cell 161, 1187-1201 (2015).
30. Orkin, S. H. Controlling the fetal globin switch in man. Nature 301, 108-109 (1983).
31. Ciofani, M. & Zúñiga-Pflücker, J. C. The thymus as an inductive site for T lymphopoiesis. Annu. Rev. Cell Dev. Biol. 23, 463-493 (2007).
32. Alt, F. W. et al. VDJ recombination. Immunol. Today 13, 306-314 (1992).
33. Gillet, N. A. et al. The host genomic environment of the provirus determines the abundance of HTLV-1-infected T-cell clones. Blood 117, 3113-3122 (2011).
34. North, T. E. et al. Runx1 expression marks long-term repopulating hematopoietic stem cells in the midgestation mouse embryo. Immunity 16, 661-672 (2002).
35. Lacaud, G. et al. Runx1 is essential for hematopoietic commitment at the hemangioblast stage of development in vitro. Blood 100, 458-466 (2002).
36. Fernandes, I. et al. Ligand-dependent nuclear receptor corepressor LCoR functions by histone deacetylase-dependent and-independent mechanisms. Mol. Cell 11, 139-150 (2003).
37. Chan, F. C. et al. An RCOR1 loss-associated gene expression signature identifies a prognostically significant DLBCL subgroup. Blood 125, 959-966 (2015).
38. Nerlov, C. & Graf, T. PU. 1 induces myeloid lineage commitment in multipotent hematopoietic progenitors. Genes Dev. 12, 2403-2412 (1998).
39. Sauvageau, G., Iscove, N. N. & Humphries, R. K. In vitro and in vivo expansion of hematopoietic stem cells. Oncogene 23, 7223-7232 (2004).
40. Ng, E. S. et al. Differentiation of human embryonic stem cells to HOXA+ hemogenic vasculature that resembles the aorta-gonad-mesonephros. Nat. Biotechnol. 34, 1168-1179 (2016).
41. Di-Poï, N., Koch, U., Radtke, F. & Duboule, D. Additive and global functions of HoxA cluster genes in mesoderm derivatives. Dev. Biol. 341, 488-498 (2010).
42. Lawrence, H. J. et al. Loss of expression of the Hoxa-9 homeobox gene impairs the proliferation and repopulating ability of hematopoietic stem cells. Blood 106, 3988-3994 (2005).
43. Ng, A. P. et al. Trisomy of Erg is required for myeloproliferation in a mouse model of Down syndrome. Blood 115, 3966-3969 (2010).
44. Loughran, S. J. et al. The transcription factor Erg is essential for definitive hematopoiesis and the function of adult hematopoietic stem cells. Nat. Immunol. 9, 810-819 (2008).
45. Huang, Y. et al. Identification and characterization of Hoxa9 binding sites in hematopoietic cells. Blood 119, 388-398 (2012).
46. Weerkamp, F. et al. Identification of Notch target genes in uncommitted T-cell progenitors: no direct induction of a T-cell specific gene program. Leukemia 20, 1967-1977 (2006).
47. Hu, Z. et al. RUNX1 regulates corepressor interactions of PU. 1. Blood 117, 6498-6508 (2011).
48. Sugimura, R. et al. Hematopoietic stem/progenitor cell conversion from human pluripotent stem cells http://dx. doi. org/10. 1038/protex. 2017. 045 (2017).
49. Loh, Y. H. et al. Reprogramming of T cells from human peripheral blood. Cell Stem Cell 7, 15-19 (2010).
50. Park, I. H. et al. Reprogramming of human somatic cells to pluripotency with defined factors. Nature 451, 141-146 (2008).
51. Meerbrey, K. L. et al. The pINDUCER lentiviral toolkit for inducible RNA interference in vitro and in vivo. Proc. Natl Acad. Sci. USA 108, 3665-3670 (2011).
52. Sankaran, V. G. et al. Developmental and species-divergent globin switching are driven by BCL11A. Nature 460, 1093-1097 (2009).
53. Kim, D. et al. TopHat2: Accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions. Genome Biol. 14, R36 (2013).
54. Anders, S., Pyl, P. T. & Huber, W. HTSeq-a Python framework to work with high-throughput sequencing data. Bioinformatics 31, 166-169 (2015).
55. Robinson, M. D., McCarthy, D. J. & Smyth, G. K. edgeR: A Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics 26, 139-140 (2010).
56. Laurenti, E. et al. The transcriptional architecture of early human hematopoiesis identifies multilevel control of lymphoid commitment. Nature Immunol. 14, 756-763 (2013).
57. Serrao, E., Cherepanov, P. & Engelman, A. N. Amplification, next-generation sequencing, and genomic DNA mapping of retroviral integration sites. J. Vis. Exp. (109): (2016).